L1061 - LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP]
TED · 741362-2026Award noticeawardedNo deadline given
Value
Estimated€1,639,392 · 1,639,392 EUR
Awarded—
WinnerVIIVHIV HEALTHCARE, UNIPESSOAL, LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 35 | — | 2026-10-27 |
| GILEAD SCIENCES, LDA | 29 | — | 2026-10-13 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 23 | €1,569,649 | 2026-10-20 |
| JANSSEN-CILAG FARMACEUTICA LDA | 19 | €371,730 | 2026-10-13 |
| NOVARTIS FARMA - PROD.FARM SA | 19 | — | 2026-10-20 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-28 | 2024/0900 - LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 98% |
| 2026-08-04 | 2024/0900 - DOLUTEGRAVIR + ABACAVIR + LAMIVUDINA [50 MG + 600 MG + 300 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-06-30 | 2024/0900 - DOLUTEGRAVIR + RILPIVIRINA [50 MG + 25 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-08-17 | C/ BASE NO CPA 2024_900 - LAMIVUDINA 300 MG + DOLUTEGRAVIR 50 MG COMP | Unidade Local de Saúde de Coimbra, EPE PT | 95% |
| 2026-06-30 | 2024/0900 - DOLUTEGRAVIR [50 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-08-11 | 2023/0492 - DURVALUMAB [50 MG/ ML 10 ML FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |